- Mylan launches generic drug for kidney transplant patients
- Generic drug prices spike, but PBMs' reimbursement rates don't keep up, NCPA study finds
- Chickenpox vaccine does not appear to increase incidence of shingles, study finds
- Study: Whooping cough vaccine may not prevent infection
- 21 health industry groups address FDA on proposed changes to generic drug label rules
PITTSBURGH — Mylan has launched a generic drug for treating herpes, the company said Wednesday.
Mylan announced the launch of famciclovir tablets in the 125-mg, 250-mg and 500-mg strengths. The drug is a generic version of Novartis’ Famvir.
Branded and generic versions of the drug had sales of $196 million in 2010, according to IMS Health.